Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$738,292.00
Award Year:
2012
Program:
STTR
Phase:
Phase II
Contract:
W911NF-12-C-0007
Agency Tracking Number:
A2-4623
Solicitation Year:
2009
Solicitation Topic Code:
A09A-T004
Solicitation Number:
2009.A
Small Business Information
Enantigen Therapeutics, Inc
Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA, 18902-8400
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
828761697
Principal Investigator:
Xiaodong PhD
President
(215) 589-6350
michaelxu@enantigen.com
Business Contact:
Kathleen MBA
Grants Administrator
(215) 489-4944
kczupich@artemis-finance.com
Research Institution:
New York University
Richard Louth
Department of Chemistry
100 Washington Square East
New York, NY, 18902-0000
(212) 998-2121
Nonprofit college or university
Abstract
This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against multidrug resistant (MDR) pathogens. In Phase I and the

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government